Copyright Reports & Markets. All rights reserved.

Global Traveler’s Diarrhea Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Traveler’s Diarrhea Treatment
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Traveler’s Diarrhea Treatment by Type
    • 1.3.1 Overview: Global Traveler’s Diarrhea Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Traveler’s Diarrhea Treatment Consumption Value Market Share by Type in 2023
    • 1.3.3 Immunization
    • 1.3.4 Non-antibiotic Agents
    • 1.3.5 Antibiotics
    • 1.3.6 Anti-Motility Agents
    • 1.3.7 Other
  • 1.4 Global Traveler’s Diarrhea Treatment Market by Application
    • 1.4.1 Overview: Global Traveler’s Diarrhea Treatment Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Adult Traveler's Diarrhea
    • 1.4.3 Children Traveler's Diarrhea
  • 1.5 Global Traveler’s Diarrhea Treatment Market Size & Forecast
  • 1.6 Global Traveler’s Diarrhea Treatment Market Size and Forecast by Region
    • 1.6.1 Global Traveler’s Diarrhea Treatment Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Traveler’s Diarrhea Treatment Market Size by Region, (2019-2030)
    • 1.6.3 North America Traveler’s Diarrhea Treatment Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Traveler’s Diarrhea Treatment Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Traveler’s Diarrhea Treatment Market Size and Prospect (2019-2030)
    • 1.6.6 South America Traveler’s Diarrhea Treatment Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Traveler’s Diarrhea Treatment Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Salix Pharmaceuticals
    • 2.1.1 Salix Pharmaceuticals Details
    • 2.1.2 Salix Pharmaceuticals Major Business
    • 2.1.3 Salix Pharmaceuticals Traveler’s Diarrhea Treatment Product and Solutions
    • 2.1.4 Salix Pharmaceuticals Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Salix Pharmaceuticals Recent Developments and Future Plans
  • 2.2 P&G
    • 2.2.1 P&G Details
    • 2.2.2 P&G Major Business
    • 2.2.3 P&G Traveler’s Diarrhea Treatment Product and Solutions
    • 2.2.4 P&G Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 P&G Recent Developments and Future Plans
  • 2.3 Johnson & Johnson
    • 2.3.1 Johnson & Johnson Details
    • 2.3.2 Johnson & Johnson Major Business
    • 2.3.3 Johnson & Johnson Traveler’s Diarrhea Treatment Product and Solutions
    • 2.3.4 Johnson & Johnson Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.4 Otsuka Pharma
    • 2.4.1 Otsuka Pharma Details
    • 2.4.2 Otsuka Pharma Major Business
    • 2.4.3 Otsuka Pharma Traveler’s Diarrhea Treatment Product and Solutions
    • 2.4.4 Otsuka Pharma Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Otsuka Pharma Recent Developments and Future Plans
  • 2.5 Valneva
    • 2.5.1 Valneva Details
    • 2.5.2 Valneva Major Business
    • 2.5.3 Valneva Traveler’s Diarrhea Treatment Product and Solutions
    • 2.5.4 Valneva Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Valneva Recent Developments and Future Plans
  • 2.6 Shanghai United Cell
    • 2.6.1 Shanghai United Cell Details
    • 2.6.2 Shanghai United Cell Major Business
    • 2.6.3 Shanghai United Cell Traveler’s Diarrhea Treatment Product and Solutions
    • 2.6.4 Shanghai United Cell Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Shanghai United Cell Recent Developments and Future Plans
  • 2.7 PaxVax
    • 2.7.1 PaxVax Details
    • 2.7.2 PaxVax Major Business
    • 2.7.3 PaxVax Traveler’s Diarrhea Treatment Product and Solutions
    • 2.7.4 PaxVax Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 PaxVax Recent Developments and Future Plans
  • 2.8 Livzon
    • 2.8.1 Livzon Details
    • 2.8.2 Livzon Major Business
    • 2.8.3 Livzon Traveler’s Diarrhea Treatment Product and Solutions
    • 2.8.4 Livzon Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Livzon Recent Developments and Future Plans
  • 2.9 Immuron
    • 2.9.1 Immuron Details
    • 2.9.2 Immuron Major Business
    • 2.9.3 Immuron Traveler’s Diarrhea Treatment Product and Solutions
    • 2.9.4 Immuron Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Immuron Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Traveler’s Diarrhea Treatment Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Traveler’s Diarrhea Treatment by Company Revenue
    • 3.2.2 Top 3 Traveler’s Diarrhea Treatment Players Market Share in 2023
    • 3.2.3 Top 6 Traveler’s Diarrhea Treatment Players Market Share in 2023
  • 3.3 Traveler’s Diarrhea Treatment Market: Overall Company Footprint Analysis
    • 3.3.1 Traveler’s Diarrhea Treatment Market: Region Footprint
    • 3.3.2 Traveler’s Diarrhea Treatment Market: Company Product Type Footprint
    • 3.3.3 Traveler’s Diarrhea Treatment Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Traveler’s Diarrhea Treatment Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Traveler’s Diarrhea Treatment Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Traveler’s Diarrhea Treatment Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Traveler’s Diarrhea Treatment Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Traveler’s Diarrhea Treatment Consumption Value by Type (2019-2030)
  • 6.2 North America Traveler’s Diarrhea Treatment Consumption Value by Application (2019-2030)
  • 6.3 North America Traveler’s Diarrhea Treatment Market Size by Country
    • 6.3.1 North America Traveler’s Diarrhea Treatment Consumption Value by Country (2019-2030)
    • 6.3.2 United States Traveler’s Diarrhea Treatment Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Traveler’s Diarrhea Treatment Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Traveler’s Diarrhea Treatment Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Traveler’s Diarrhea Treatment Consumption Value by Type (2019-2030)
  • 7.2 Europe Traveler’s Diarrhea Treatment Consumption Value by Application (2019-2030)
  • 7.3 Europe Traveler’s Diarrhea Treatment Market Size by Country
    • 7.3.1 Europe Traveler’s Diarrhea Treatment Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Traveler’s Diarrhea Treatment Market Size and Forecast (2019-2030)
    • 7.3.3 France Traveler’s Diarrhea Treatment Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Traveler’s Diarrhea Treatment Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Traveler’s Diarrhea Treatment Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Traveler’s Diarrhea Treatment Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Traveler’s Diarrhea Treatment Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Traveler’s Diarrhea Treatment Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Traveler’s Diarrhea Treatment Market Size by Region
    • 8.3.1 Asia-Pacific Traveler’s Diarrhea Treatment Consumption Value by Region (2019-2030)
    • 8.3.2 China Traveler’s Diarrhea Treatment Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Traveler’s Diarrhea Treatment Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Traveler’s Diarrhea Treatment Market Size and Forecast (2019-2030)
    • 8.3.5 India Traveler’s Diarrhea Treatment Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Traveler’s Diarrhea Treatment Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Traveler’s Diarrhea Treatment Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Traveler’s Diarrhea Treatment Consumption Value by Type (2019-2030)
  • 9.2 South America Traveler’s Diarrhea Treatment Consumption Value by Application (2019-2030)
  • 9.3 South America Traveler’s Diarrhea Treatment Market Size by Country
    • 9.3.1 South America Traveler’s Diarrhea Treatment Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Traveler’s Diarrhea Treatment Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Traveler’s Diarrhea Treatment Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Traveler’s Diarrhea Treatment Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Traveler’s Diarrhea Treatment Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Traveler’s Diarrhea Treatment Market Size by Country
    • 10.3.1 Middle East & Africa Traveler’s Diarrhea Treatment Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Traveler’s Diarrhea Treatment Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Traveler’s Diarrhea Treatment Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Traveler’s Diarrhea Treatment Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Traveler’s Diarrhea Treatment Market Drivers
  • 11.2 Traveler’s Diarrhea Treatment Market Restraints
  • 11.3 Traveler’s Diarrhea Treatment Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Traveler’s Diarrhea Treatment Industry Chain
  • 12.2 Traveler’s Diarrhea Treatment Upstream Analysis
  • 12.3 Traveler’s Diarrhea Treatment Midstream Analysis
  • 12.4 Traveler’s Diarrhea Treatment Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Traveler’s Diarrhea Treatment market size was valued at USD 808.1 million in 2023 and is forecast to a readjusted size of USD 1020.7 million by 2030 with a CAGR of 3.4% during review period.
    Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    The Global Info Research report includes an overview of the development of the Traveler’s Diarrhea Treatment industry chain, the market status of Adult Traveler's Diarrhea (Immunization, Non-antibiotic Agents), Children Traveler's Diarrhea (Immunization, Non-antibiotic Agents), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Traveler’s Diarrhea Treatment.
    Regionally, the report analyzes the Traveler’s Diarrhea Treatment markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Traveler’s Diarrhea Treatment market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Traveler’s Diarrhea Treatment market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Traveler’s Diarrhea Treatment industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Immunization, Non-antibiotic Agents).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Traveler’s Diarrhea Treatment market.
    Regional Analysis: The report involves examining the Traveler’s Diarrhea Treatment market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Traveler’s Diarrhea Treatment market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Traveler’s Diarrhea Treatment:
    Company Analysis: Report covers individual Traveler’s Diarrhea Treatment players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Traveler’s Diarrhea Treatment This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Adult Traveler's Diarrhea, Children Traveler's Diarrhea).
    Technology Analysis: Report covers specific technologies relevant to Traveler’s Diarrhea Treatment. It assesses the current state, advancements, and potential future developments in Traveler’s Diarrhea Treatment areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Traveler’s Diarrhea Treatment market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Traveler’s Diarrhea Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Immunization
    Non-antibiotic Agents
    Antibiotics
    Anti-Motility Agents
    Other
    Market segment by Application
    Adult Traveler's Diarrhea
    Children Traveler's Diarrhea
    Market segment by players, this report covers
    Salix Pharmaceuticals
    P&G
    Johnson & Johnson
    Otsuka Pharma
    Valneva
    Shanghai United Cell
    PaxVax
    Livzon
    Immuron
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Traveler’s Diarrhea Treatment product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Traveler’s Diarrhea Treatment, with revenue, gross margin and global market share of Traveler’s Diarrhea Treatment from 2019 to 2024.
    Chapter 3, the Traveler’s Diarrhea Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Traveler’s Diarrhea Treatment market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Traveler’s Diarrhea Treatment.
    Chapter 13, to describe Traveler’s Diarrhea Treatment research findings and conclusion.

    Buy now